CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages
A Papin, B Tessoulin, C Bellanger, A Moreau, Y Le Bris… - Leukemia, 2019 - nature.com
The microenvironment strongly influences mantle cell lymphoma (MCL) survival,
proliferation, and chemoresistance. However, little is known regarding the molecular …
proliferation, and chemoresistance. However, little is known regarding the molecular …
[HTML][HTML] The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition
S Decombis, A Papin, C Bellanger, C Sortais… - …, 2022 - ncbi.nlm.nih.gov
Aggressive B-cell malignancies, such as mantle cell lymphoma (MCL), are
microenvironment-dependent tumors and a better understanding of the dialogs occurring in …
microenvironment-dependent tumors and a better understanding of the dialogs occurring in …
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma
Mantle cell lymphoma (MCL) is an aggressive form of non-Hodgkin B-cell lymphoma with
poor prognosis due to drug resistance. Introduction of the Bruton tyrosine kinase (BTK) …
poor prognosis due to drug resistance. Introduction of the Bruton tyrosine kinase (BTK) …
Racial and socioeconomic disparities in mantle cell lymphoma
Background Although race and socioeconomic factors are associated with outcome in many
malignancies, few studies have examined the effect of race and socioeconomic status on …
malignancies, few studies have examined the effect of race and socioeconomic status on …
The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma
L Benaniba, B Tessoulin, S Trudel… - BMC cancer, 2019 - Springer
Background Despite recent advances in the treatment of multiple myeloma, the disease
constantly relapses and is still considered as incurable. The current knowledge about the …
constantly relapses and is still considered as incurable. The current knowledge about the …
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group
Y Le Bris, F Magrangeas, A Moreau… - Hematological …, 2020 - Wiley Online Library
Mantle cell lymphoma (MCL) is a lymphoproliferative disorder characterized by the t (11;
14)(q13; q32) CCND1/IGH translocation. This lymphoma is however extremely …
14)(q13; q32) CCND1/IGH translocation. This lymphoma is however extremely …
Pre‐treatment health‐related quality of life parameters have prognostic impact in patients> 65 years with newly diagnosed mantle cell lymphoma: The Nordic …
Å Lindberg, CW Eskelund… - Hematological …, 2022 - Wiley Online Library
Mantle cell lymphoma (MCL) is a rare, often aggressive type of B‐cell lymphoma with poor
survival and no cure. Cancer and cancer treatment has a negative impact on health‐related …
survival and no cure. Cancer and cancer treatment has a negative impact on health‐related …
[PDF][PDF] Habilitation à Diriger les Recherches _ Habilitation à Diriger les Recherches
D Chiron - 2022 - inserm.hal.science
Mantle cell lymphoma (MCL), a non-Hodgkin lymphoma of pregerminal center mature B
cells, remains incurable due to the development of drug resistance (1). Bruton tyrosine …
cells, remains incurable due to the development of drug resistance (1). Bruton tyrosine …
[PDF][PDF] Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
OH Deceunynck, MH Delfau-Larue13, B Tessoulin… - researchgate.net
Mantle cell lymphoma (MCL) is a lymphoproliferative disorder characterized by the t (11;
14)(q13; q32) CCND1/IGH translocation. This lymphoma is however extremely …
14)(q13; q32) CCND1/IGH translocation. This lymphoma is however extremely …
[HTML][HTML] CSF1R and BTK inhibitions as novel strategies to disrupt the dialogue between mantle cell lymphoma and macrophages
A Papin, B Tessoulin, C Bellanger, A Moreau, YLE Bris… - Blood, 2018 - Elsevier
The aggressive clinical behavior of mantle cell lymphoma (MCL) and its short-term response
to treatments highlight a need for novel options. The microenvironment strongly controls …
to treatments highlight a need for novel options. The microenvironment strongly controls …